Genmab A/S (GE9.F)

EUR 194.65

(2.93%)

Total Liabilities Summary of Genmab A/S

  • Genmab A/S's latest annual total liabilities in 2023 was 493.39 Million EUR , up 29.71% from previous year.
  • Genmab A/S's latest quarterly total liabilities in 2024 Q2 was 1.02 Billion EUR , up 82.95% from previous quarter.
  • Genmab A/S reported annual total liabilities of 380.38 Million EUR in 2022, up 16.37% from previous year.
  • Genmab A/S reported annual total liabilities of 326.87 Million EUR in 2021, up 20.33% from previous year.
  • Genmab A/S reported quarterly total liabilities of 559.41 Million EUR for 2024 Q1, up 13.38% from previous quarter.
  • Genmab A/S reported quarterly total liabilities of 493.39 Million EUR for 2023 FY, up 29.71% from previous quarter.

Annual Total Liabilities Chart of Genmab A/S (2023 - 2016)

Historical Annual Total Liabilities of Genmab A/S (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 493.39 Million EUR 29.71%
2022 380.38 Million EUR 16.37%
2021 326.87 Million EUR 20.33%
2020 271.64 Million EUR 85.21%
2019 146.67 Million EUR 145.06%
2018 59.85 Million EUR 34.73%
2017 44.42 Million EUR -19.74%
2016 55.34 Million EUR 0.0%

Peer Total Liabilities Comparison of Genmab A/S

Name Total Liabilities Total Liabilities Difference
ADV.BLOCKCHAIN AG INH ON 4.93 Million EUR -9901.559%
Branicks Group AG 83.56 Million EUR -490.422%
aifinyo AG 46.39 Million EUR -963.38%
The Platform Group AG 202.73 Million EUR -143.366%